Wilson Troy Edward's Form 4 filing
Kura Oncology, Inc. (KURA) · filed Sep 29, 2025
- Accession no.
- 0001193125-25-223663
- Filed
- Sep 29, 2025
- Trade date
- Sep 27-29, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $327.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wilson Troy EdwardCIK 0001589597 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 27, 2025 | Common Stock | AGrant or awardAcquired | +182,500 | $0.00 | $0 | 283,468 | Direct | |
| Sep 29, 2025 | Common Stock | SSaleDisposed | −36,615 | $8.94 | −$327,338.1 | 246,853 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.